MFDS — authorised 26 May 2023
- Marketing authorisation holder: LEXICON PHARMS INC
- Status: likely_approved
🇰🇷 Inpefa in South Korea
MFDS authorised Inpefa on 26 May 2023
Marketing authorisation
Inpefa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Inpefa approved in South Korea?
Yes. MFDS authorised it on 26 May 2023.
Who is the marketing authorisation holder for Inpefa in South Korea?
LEXICON PHARMS INC holds the South Korean marketing authorisation.